SEC Form 4 · accession 0001209191-18-031396
Azenta, Inc. · AZTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maurice H. Tenney
Officer — President-Brooks Life Sciences
Period of report
May 16, 2018
Accepted (ET)
May 18, 2018 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000933974
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 16, 2018 | S | 8,969 | $29.80 | D | 147,829 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $29.75 to $29.85. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.